Bayer CropScience Q2 FY27 results: revenue Rs 1,250.70 cr, PAT Rs 166.20 cr
Results$BAYERCROP

Bayer CropScience Q2 FY27 results: revenue Rs 1,250.70 cr, PAT Rs 166.20 cr

Bayer CropScience standalone Q2 FY27 revenue was Rs 1,250.70 cr and PAT Rs 166.20 cr, versus Rs 1,553.40 cr and Rs 152.70 cr a year earlier.

Bayer CropScience Ltd
Bayer CropScience LtdReviewed and published by · How we report
3 min read
bayer cropscienceq2 fy27 resultsquarterly earningspatrevenue
ShareWhatsAppXLinkedIn

Key takeaways

  • Revenue from operations Q2 FY27 Rs 1,250.70 cr vs Rs 1,553.40 cr in Q2 FY26
  • Total income Q2 FY27 Rs 1,264.10 cr vs Rs 1,567.20 cr a year earlier
  • Total expenses Q2 FY27 Rs 1,052.70 cr vs Rs 1,366.90 cr in Q2 FY26
  • PAT Q2 FY27 Rs 166.20 cr vs Rs 152.70 cr in the prior-year quarter
  • EPS Q2 FY27 Rs 36.98^ vs Rs 33.98^ in the corresponding quarter

Q2 FY27 · standalone

MetricSep 2026Sep 2025Change
RevenueRs 1,250.70 crRs 1,553.40 cr-19.5%
PATRs 166.20 crRs 152.70 cr+8.8%

As reported in the filing. Figures are transcribed, not computed.

What the numbers show

  • Net margin was 13.29% of revenue, up 345 bps from 9.83%.
  • Revenue fell 19.5% while total expenses fell 23.0%.
  • Changes in inventories accounted for Rs 246.40 cr of the Rs 314.20 cr fall in total expenses (78%).
  • Cost of materials took 57.4% of revenue, against 46.1% a year earlier.

• Revenue from operations (Q2 FY27): Rs 1,250.70 cr (Q2 FY26: Rs 1,553.40 cr)
• Total income (Q2 FY27): Rs 1,264.10 cr (Q2 FY26: Rs 1,567.20 cr)
• Total expenses (Q2 FY27): Rs 1,052.70 cr (Q2 FY26: Rs 1,366.90 cr)
• Cost of materials consumed (Q2 FY27): Rs 717.90 cr (Q2 FY26: Rs 715.90 cr)
• Purchases of stock-in-trade (Q2 FY27): Rs 38.40 cr (Q2 FY26: Rs 102.10 cr)
• Changes in inventories of finished goods, work-in-progress and stock-in-trade (Q2 FY27): Rs (42.80) cr (Q2 FY26: Rs 203.60 cr)
• Employee benefits expense (Q2 FY27): Rs 105.50 cr (Q2 FY26: Rs 112.50 cr)
• Finance costs (Q2 FY27): Rs 4.70 cr (Q2 FY26: Rs 4.40 cr)
• Depreciation and amortisation expense (Q2 FY27): Rs 15.00 cr (Q2 FY26: Rs 14.40 cr)
• Other expenses (Q2 FY27): Rs 214.00 cr (Q2 FY26: Rs 214.00 cr)
• Profit before tax (Q2 FY27): Rs 211.40 cr (Q2 FY26: Rs 200.30 cr)
• Profit for the period / year (PAT) (Q2 FY27): Rs 166.20 cr (Q2 FY26: Rs 152.70 cr)
• Earnings per share – basic and diluted (Q2 FY27): Rs 36.98^ (Q2 FY26: Rs 33.98^)

According to the statement of unaudited financial results for the quarter ended 30.09.2026 (standalone), Bayer CropScience Limited reported revenue from operations of Rs 1,250.70 cr for the quarter ended 30.09.2026, compared with Rs 1,553.40 cr in the corresponding quarter ended 30.09.2025. Total income for the quarter was Rs 1,264.10 cr versus Rs 1,567.20 cr a year earlier, with other income at Rs 13.40 cr against Rs 13.80 cr in the prior-year quarter.

Total expenses for the quarter were Rs 1,052.70 cr, down from Rs 1,366.90 cr in the same quarter last year. Within this, cost of materials consumed was Rs 717.90 cr (Q2 FY26: Rs 715.90 cr), purchases of stock-in-trade were Rs 38.40 cr (Q2 FY26: Rs 102.10 cr), and changes in inventories of finished goods, work-in-progress and stock-in-trade stood at Rs (42.80) cr compared with Rs 203.60 cr a year earlier. Employee benefits expense was Rs 105.50 cr versus Rs 112.50 cr, finance costs were Rs 4.70 cr versus Rs 4.40 cr, depreciation and amortisation expense was Rs 15.00 cr versus Rs 14.40 cr, and other expenses were unchanged at Rs 214.00 cr versus Rs 214.00 cr in the corresponding quarter.

Profit before tax for the quarter ended 30.09.2026 was Rs 211.40 cr, compared with Rs 200.30 cr in the quarter ended 30.09.2025. After a total tax expense of Rs 45.20 cr (Q2 FY26: Rs 47.60 cr), profit for the period was Rs 166.20 cr, up from Rs 152.70 cr in the year-ago quarter. Earnings per share (basic and diluted, not annualised) for the quarter were Rs 36.98^, compared with Rs 33.98^ in the corresponding quarter of the previous year, as disclosed in the statement of financial results.

Track Bayer CropScience Ltd

Cruxal reads every Bayer CropScience Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.

Bayer CropScience Q2 FY27 Results: Revenue Rs 1,250.70 cr | Cruxal